Abstract
Innovative pharmacogenomic approaches (genetic variation related to medication response) are needed to reduce disease and disparities in Indigenous communities. We support community-based pharmacogenomics research, inclusive of Indigenous values and priorities, to improve the health and well-being of Indigenous peoples.
| Original language | English |
|---|---|
| Article number | 920 |
| Pages (from-to) | 920 |
| Journal | Nature Communications |
| Volume | 15 |
| Issue number | 1 |
| DOIs |
|
| State | Published - Jan 31 2024 |
Funding
We thank Drs. Wylie Burke, Sara Hull, Ajay Israni, Pamala Jacobson, Bill Oetting, Kenneth Thummel, and Dave Wilson for their feedback on early drafts. We thank Tadeusz Wroblewski for his assistance with the figure. This work was supported by NIH grants R35HG011319 (K.G.C., E.L.W.), K01AI130409 (C.R.D.), P01GM116691 (E.L.W.), and R01HG009500 (E.L.W.).
| Funder number |
|---|
| R35HG011319, K01AI130409, R01HG009500, P01GM116691 |
Keywords
- Humans
- Pharmacogenetics
- Delivery of Health Care
- Health Services, Indigenous
Fingerprint
Dive into the research topics of 'Implementing community-engaged pharmacogenomics in Indigenous communities'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver